Relationship between 25-hydroxyvitamin D and newly diagnosed type 2 diabetes mellitus in postmenopausal women with osteoporosis

Medical Principles and Practice

Volumn 23, Issue 3, 2014, Pages 229-233

  Vujosevic, Snezana ^a   Borozan, Sanja ^a   Radojevic, Nemanja ^a   Aligrudic, Svetlana ^a   Bozovic, Dragica ^a  

^a UNIVERSITY OF MONTENEGRO   (Montenegro)

Author keywords

25 Hydroxyvitamin D; Osteoporosis; Type 2 diabetes mellitus

Indexed keywords

25 HYDROXYVITAMIN D; CHOLESTEROL; TRIACYLGLYCEROL; 25-HYDROXYVITAMIN D; LIPID; VITAMIN D; CALCIUM; GLUCOSE; IBANDRONIC ACID;

ADULT; AGED; ARTICLE; BODY MASS; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; COMORBIDITY; DISEASE ASSOCIATION; FEMALE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MENOPAUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; PROGNOSIS; PROSPECTIVE STUDY; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN BLOOD LEVEL; VITAMIN DEFICIENCY; ANALOGS AND DERIVATIVES; BLOOD; DIABETES MELLITUS, TYPE 2; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; SENSITIVITY AND SPECIFICITY; VITAMIN D DEFICIENCY; CHEMILUMINESCENCE IMMUNOASSAY; DISEASE PREDISPOSITION; GLUCOSE BLOOD LEVEL; INCIDENCE; ORAL GLUCOSE TOLERANCE TEST; PREDICTIVE VALUE; VITAMIN SUPPLEMENTATION;

ADULT; AGED; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN RESISTANCE; LIPIDS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84901594402     PISSN: 10117571     EISSN: 14230151     Source Type: Journal    
DOI: 10.1159/000360540     Document Type: Article

References (22)

1. International Diabetes Federation, 2012: The Global Burden (accessed September 27, 2013). http://www.idf.org/diabetesatlas/5e/ the-global-burden.
2. Pittas AG, Dawson-Hughes B: The role of vitamin D in type 2 diabetes and hypertension; in Feldman D, Pike JW, Adams J (eds): Vitamin D, ed 3. Philadelphia, Elsevier, 2011, p 1907.
3. Brock KE, Huang WY, Fraser DR, et al: Diabetes prevalence is associated with serum 25-hydroxyvitamin D and 1.25-dihydroxyvitamin D in US middle-aged Caucasian men and women: A cross-sectional analysis within the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Br J Nutr 2011; 106: 339-344.
4. Afzal S, Bojesen SE, Nordestgaard BG: Low 25-hydroxyvitamin D and risk of type 2 diabetes: A prospective cohort study and metaanalysis. Clin Chem 2013; 59: 381-391.
5. Perez-Lopez FR: Vitamin D and its implications for musculoskeletal health in women: An update. Maturitas 2007; 58: 117-137.
6. Norman AW, Frankel JB, Heldt AM, et al: Vitamin D deficiency inhibits pancreatic secretion of insulin. Science 1980; 209: 823-825.
7. Li L, Wu B, Liu JY, et al: Vitamin D receptor gene polymorphisms and type 2 diabetes: A meta-analysis. Arch Med Res 2013; 44: 235-241.
8. Boucher BJ: Is vitamin D status relevant to metabolic syndrome? Dermatoendocrinol 2012; 4: 212-224.
9. De Paula FJ, Horowitz MC, Rosen CJ: Novel insights into relationship between diabetes and osteoporosis. Diabetes Metab Res Rev 2010; 26: 622-630.
10. Boucher BJ: Vitamin D deficiency and diabetes risk. Curr Drug Targets 2011; 12: 61-87.
11. Michael FH, Tai CC: Vitamin D deficiency: A worldwide problem with health consequences. Am J Clin Nutr 2008; 87: 1080S-1086S.
12. Kanis JA: Diagnosis of osteoporosis and assessment of fracture risk. Lancet 2002; 359: 1929-1936.
13. International Diabetes Federation, 2012: Global Guideline for Type 2 Diabetes (accessed September 19, 2013). http://www.idf. org.
14. Balkau B, Charles MA: Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med 1999; 16: 442-443.
15. Lee S, Clark SA, Gill RK, et al: 1.25-Dihydroxyvitamin D3 and pancreatic beta-cell function: vitamin D receptors, gene expression and insulin secretion. Endocrinology 1994; 134: 1602-1610.
16. Pittas AG, Dawson-Hughes B, Li T, et al: Vitamin D and calcium intake in relation to type diabetes in women. Diabetes Care 2006; 29: 650-656.
17. Pittas AG, Lau J, Hu FB, et al: The role of vitamin D and calcium in type 2 diabetes mellitus. A systematic review and meta-analysis. J Clin Endocrinol Metab 2007; 92: 2017-2029.
18. Pilz S, Kienreich K, Rutters F, et al: Role of vitamin D in the development of insulin resistance and type 2 diabetes. Curr Diab Rep 2013; 13: 261-270.
19. MacDonald HM, Mavroedi A, Barr RJ, et al: Vitamin D status in postmenopausal women living at higher latitudes in the UK in relation to bone health, overweight, sunlight exposure and dietary vitamin D. Bone 2008; 42: 996-1003.
20. Brazdilova K, Dlesk A, Koller T, et al: Vitamin D deficiency-a possible link between osteoporosis and metabolic syndrome. Bratisl Lek Listy 2012; 113: 412-416.
21. McGill AT, Stewart JM, Lithander FE, et al: Relationship of low serum vitamin D3 with anthropometry and markers of the metabolic syndrome and diabetes in overweight and obesity. Nutr J 2008; 7: 4.
22. Wortsman J, Matsuoka LY, Chen TC, et al: Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000; 72: 690-693.